Back to Jobs
Mineralys Therapeutics
Data Science & Analytics 14h ago

Director, Market Research & Competitive Intelligence

Mineralys Therapeutics
United StatesUnited States
Full-time
$190,000 - $220,000
Senior-Level

Job Description

Key Skills Required

Master these to land this role

Market ResearchData AnalyticsBusiness IntelligenceCompetitive IntelligenceSpreadsheets (Excel)

Want to know if you're a match for this job?

Calculate My Match Score

The Director, Market Research & Competitive Intelligence will be responsible for primary & secondary market research/analytics & competitive intelligence to support the development & launch of lorundrostat.

Position Summary:

Create strategic frameworks to help Mineralys organize & prioritize key business questions around commercial planning, lifecycle management.

  • Proactively manage multiple third-party vendors, data providers & consultants to generate insights & data to support key business decisions for the organization including commercial as well as various cross-functional partners.
  • Work with marketing & market access to develop strategic commercial plans for the launch of lorundrostat in uncontrolled / resistant hypertension.
  • Answer or provide commercial perspective on ad hoc literature review / epidemiology / commercial opportunity related questions to support BD, senior leadership questions, external presentations (for investors, earnings, etc.), BoD presentations, Leadership Team presentations.
  • Monitor and disseminate competitive activity in therapeutic areas (TAs) of interest to the broader organization.
  • Provide input on revenue forecast updates/development.
  • Efficiently manage business insights budget planning & spend.
  • This role will report to the Exec. Director of Business Analytics & Competitive Intelligence.

Skills and Attributes:

  • Proficient in PowerPoint and Excel; expertise in creating clear & attractive presentations & frameworks is required.
  • Strong knowledge of the US pharmaceutical market (preferably in general medicine, cardiovascular, metabolic, renal, or other larger prevalence therapeutic areas).
  • Some knowledge/experience with the US payer/market access environment and data sources is preferred.
  • Some knowledge/experience of major ex-US pharmaceutical markets is preferred but not required.
  • Working experience with US data sources for market data (claims/EHR/Rx/audits/Payer Coverage/Competitive Intelligence databases) is required.
  • Working knowledge of the drug development process and ability to evaluate competitive clinical trial design is required.

Education and Experience:

  • A Bachelor’s degree or equivalent experience is required.
  • Minimum of 8 years in market research, data analytics, business intelligence, competitive intelligence, marketing, or other related discipline within commercial pharmaceutical or biotech located in the US.

Travel:

  • This position requires up to 10% travel, frequently outside the local area and overnight.

How would you rate this job post?

See what other professionals think about this role.

banner
logo

Mineralys Therapeutics

View Company Profile

Mineralys Therapeutics is a clinical-stage biopharmaceutical company engineered to pioneer targeted therapies for cardiorenal metabolic diseases driven by abnormally elevated or dysregulated aldosterone levels. Operating at the frontier of precision pharmacology, the company eliminates the therapeutic ceiling of legacy antihypertensive treatments—which routinely fail over 30 million U.S. patients suffering from uncontrolled or resistant hypertension—by developing lorundrostat, a novel, orally administered, highly selective aldosterone synthase inhibitor (ASI). Moving beyond broad-spectrum blood pressure medications and non-selective mineralocorticoid receptor antagonists, Mineralys Therapeutics equips healthcare systems with clinical-stage small molecules designed to stop aldosterone hyper-production directly at its enzymatic source, significantly reducing systemic vascular strain and organ damage with targeted, once-daily precision. Under the hood, its clinical development engine—bolstered by Phase 2/3 trial data (Target-HTN), biomarker-driven patient selection, and robust cardiorenal clinical protocols—natively targets resistant hypertension, chronic kidney disease (CKD), and obstructive sleep apnea. What sets Mineralys Therapeutics apart is its laser focus on the root metabolic drivers of cardiovascular disease; by selectively inhibiting aldosterone synthesis while preserving systemic hormone balance, the firm enables clinicians to break treatment resistance, protect vital organ architecture, and set a new therapeutic standard in cardiovascular and renal health.

Safety First

  • Never pay for a job application.
  • Do not share sensitive bank info.
  • Verify the client before starting work.
Learn More
Director, Market Research & Competitive Intelligence at Mineralys Therapeutics | HireSkys